FLT3 and acute myeloid leukemia: Conversely, in another study by the same team examining PB from 20 newly diagnosed AML patients, those with FLT3 mutations exhibited an extremely low proportion of NK cells and markedly abnormal expression levels of the inhibitory receptor CD159a (8).